
J&J's 'Swiss army knife' drug gets first FDA approval
Johnson & Johnson has its first regulatory approval for FcRn blocker Imaavy, getting a green light in the US for the would-be blockbuster as a treatment for generalised myasthenia gravis (gMG). It isn't the first drug in the class to be cleared by …